Your browser doesn't support javascript.
loading
Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.
Koga, Masatoshi; Yamamoto, Haruko; Inoue, Manabu; Asakura, Koko; Aoki, Junya; Hamasaki, Toshimitsu; Kanzawa, Takao; Kondo, Rei; Ohtaki, Masafumi; Itabashi, Ryo; Kamiyama, Kenji; Iwama, Toru; Nakase, Taizen; Yakushiji, Yusuke; Igarashi, Shuichi; Nagakane, Yoshinari; Takizawa, Shunya; Okada, Yasushi; Doijiri, Ryosuke; Tsujino, Akira; Ito, Yasuhiro; Ohnishi, Hideyuki; Inoue, Takeshi; Takagi, Yasushi; Hasegawa, Yasuhiro; Shiokawa, Yoshiaki; Sakai, Nobuyuki; Osaki, Masato; Uesaka, Yoshikazu; Yoshimura, Shinichi; Urabe, Takao; Ueda, Toshihiro; Ihara, Masafumi; Kitazono, Takanari; Sasaki, Makoto; Oita, Akira; Yoshimura, Sohei; Fukuda-Doi, Mayumi; Miwa, Kaori; Kimura, Kazumi; Minematsu, Kazuo; Toyoda, Kazunori.
Afiliación
  • Koga M; From the Department of Cerebrovascular Medicine (M.K., M. Inoue, S. Yoshimura, M.F.-D., K. Miwa, K. Minematsu, K. Toyoda).
  • Yamamoto H; Center for Advancing Clinical and Translational Sciences (H.Y.), National Cerebral and Cardiovascular Center, Suita.
  • Inoue M; From the Department of Cerebrovascular Medicine (M.K., M. Inoue, S. Yoshimura, M.F.-D., K. Miwa, K. Minematsu, K. Toyoda).
  • Asakura K; Department of Data Science (K.A., T.H., M.F-D.), National Cerebral and Cardiovascular Center, Suita.
  • Aoki J; Department of Neurology, Graduate School of Medicine, Nippon Medical School, Tokyo (J.A., K. Kimura).
  • Hamasaki T; Department of Data Science (K.A., T.H., M.F-D.), National Cerebral and Cardiovascular Center, Suita.
  • Kanzawa T; Department of Stroke Medicine, Institute of Brain and Blood Vessels, Mihara Memorial Hospital, Isesaki (T. Kanzawa).
  • Kondo R; Department of Neurosurgery, Yamagata City Hospital Saiseikan (R. Kondo).
  • Ohtaki M; Department of Neurosurgery, Obihiro Kosei Hospital (M. Ohtaki).
  • Itabashi R; Department of Stroke Neurology, Kohnan Hospital, Sendai (R.I.).
  • Kamiyama K; Department of Neurosurgery, Nakamura Memorial Hospital, Sapporo (K. Kamiyama).
  • Iwama T; Department of Neurosurgery, Gifu University School of Medicine (T. Iwama).
  • Nakase T; Department of Stroke Science, Research Institute for Brain and Blood Vessels, Akita (T.N.).
  • Yakushiji Y; Department of Neurosurgery, Akita University (T.N.).
  • Igarashi S; Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine (Y.Y.).
  • Nagakane Y; Department of Neurology, Niigata City General Hospital (S.I.).
  • Takizawa S; Department of Neurology, Kyoto Second Red Cross Hospital (Y.N.).
  • Okada Y; Division of Neurology, Department of Internal Medicine, Tokai University School of Medicine, Isehara (S.T.).
  • Doijiri R; Department of Cerebrovascular Medicine and Neurology, Cerebrovascular Center, National Hospital Organization Kyushu Medical Center, Fukuoka (Y.O.).
  • Tsujino A; Department of Neurology, Iwate Prefectural Central Hospital, Morioka (R.D.).
  • Ito Y; Department of Neurology and Strokology, Nagasaki University Graduate School of Biomedical Sciences (A.T.).
  • Ohnishi H; Department of Neurology, Toyota Memorial Hospital (Y.I.).
  • Inoue T; Department of Neurosurgery, Ohnishi Neurological Center, Akashi (H.O.).
  • Takagi Y; Department of Stroke Medicine, Kawasaki Medical School General Medical Center, Okayama (T. Inoue).
  • Hasegawa Y; Department of Neurosurgery, Tokushima University (Y.T.).
  • Shiokawa Y; Department of Neurology, St. Marianna University School of Medicine, Kawasaki (Y.H.).
  • Sakai N; Department of Neurosurgery, Kyorin University School of Medicine, Mitaka (Y.S.).
  • Osaki M; Department of Neurosurgery, Kobe City Medical Center General Hospital (N.S.).
  • Uesaka Y; Department of Cerebrovascular Medicine, Stroke Center, Steel Memorial Yawata Hospital, Kitakyushu (M.O.).
  • Yoshimura S; Department of Neurology, Toranomon Hospital, Tokyo (Y.U.).
  • Urabe T; Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya (S. Yoshimura).
  • Ueda T; Department of Neurology, Juntendo University Urayasu Hospital (T. Urabe).
  • Ihara M; Department of Strokology, Stroke Center, St. Marianna University Toyoko Hospital, Kawasaki (T. Ueda).
  • Kitazono T; Department of Neurology (M. Ihara), National Cerebral and Cardiovascular Center, Suita.
  • Sasaki M; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka (T. Kitazono).
  • Oita A; Institute for Biomedical Sciences, Iwate Medical University, Yahaba (M.S.).
  • Yoshimura S; Department of Pharmacy (A.O.), National Cerebral and Cardiovascular Center, Suita.
  • Fukuda-Doi M; From the Department of Cerebrovascular Medicine (M.K., M. Inoue, S. Yoshimura, M.F.-D., K. Miwa, K. Minematsu, K. Toyoda).
  • Miwa K; From the Department of Cerebrovascular Medicine (M.K., M. Inoue, S. Yoshimura, M.F.-D., K. Miwa, K. Minematsu, K. Toyoda).
  • Kimura K; Department of Data Science (K.A., T.H., M.F-D.), National Cerebral and Cardiovascular Center, Suita.
  • Minematsu K; From the Department of Cerebrovascular Medicine (M.K., M. Inoue, S. Yoshimura, M.F.-D., K. Miwa, K. Minematsu, K. Toyoda).
  • Toyoda K; Department of Neurology, Graduate School of Medicine, Nippon Medical School, Tokyo (J.A., K. Kimura).
Stroke ; 51(5): 1530-1538, 2020 05.
Article en En | MEDLINE | ID: mdl-32248771
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia Trombolítica / Activador de Tejido Plasminógeno / Accidente Cerebrovascular / Fibrinolíticos / Tiempo de Tratamiento Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia Trombolítica / Activador de Tejido Plasminógeno / Accidente Cerebrovascular / Fibrinolíticos / Tiempo de Tratamiento Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Año: 2020 Tipo del documento: Article